STAT

Opinion: Fundraising in academia and the Epstein problem

The Great Dome at MIT

In the high-rolling context of academic philanthropy and fundraising, convicted sexual predator Jeffrey Epstein made gifts to elite universities, including Harvard and MIT, that were modest in size and impact. Had his sordid crimes and recent suicide not attracted massive media attention, his gifts would likely have gone unnoticed by few beyond those directly benefiting from them.

But donations he made to the MIT Media Lab after his 2008 conviction, and revelations by The New Yorker’s investigative journalists that the Media Lab covered up key details of his philanthropy, provoked the resignation of Joi Ito, the Lab’s well-connected director, and could threaten the reputation of other university leaders pending external investigations of who knew what when.

What was the context in which events like this might occur?

Philanthropy is essential to the operating budgets and long-range planning of academic institutions. Though this might come as a surprise to some, philanthropy may be more important for the largest and most elite research-intensive institutions, despite their endowments. Their broad scope of activities

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks